-
P570: Assay the interaction of 1000s of individual T cells and antigen-presenting cells for CAR-T or TCR screening in 24hrs.
#SITC2019#Tcells#immunoncology pic.twitter.com/Kcrdn0obKL -
Relaxing time for networking
#immunoncology work module@CIBERONCpic.twitter.com/eMRL2nguR1
-
Thrilling findings on Tregs as prediction and eventually dynamic risk profiling (?!) in breast k patients
#TME#Tregs#precisiononcology#immunoncology@OncoAlerthttps://twitter.com/NatRevClinOncol/status/1149324969094123525 … -
Checkpoint blockade is turning heads in the oncology community, but only for some patients. Could HSP90 be a solution?
#immunoncology https://www.bellbrooklabs.com/enhancing-checkpoint-blockade-immuno-therapy-sensitizing-tumors-hsp90-inhibitors/ …pic.twitter.com/Ney7lXuphk
-
Happy 25th anniversary to Immunity from the
#LladserLab@AlvaroLladser Happy to be part of the#ImmunityCommunity@ImmunityCP https://www.cell.com/pb-assets/journals/research/immunity/community/immunity-gallery.html …#immunoncology http://www.cienciavida.org/research/immunoncology/ … https://twitter.com/AlvaroLladser/status/1099332493554208769/photo/1pic.twitter.com/3srKQZKiZ9 pic.twitter.com/6arqOEXSw6
-
If you care for immune related-pneumonitis come to see our poster: "P2.04-79 - High Rate of Immune Related Pneumonitis in Lung Cancer Patients Treated with Anti PD-1 Antibodies" 9th Sept 2019 (10:15 - 18:15) at
#WCLC19#IASLC#Immunoncology -
Pleasure to take a part in the development of a new
#immunoncology agent. Porgador's lab generated anti-PCNA#Ab that actives NK Cells.@BenGurionUni@SorokaMed@aacr@CancerImmunothe@NKcellBiology@CIR_aacrhttp://cancerimmunolres.aacrjournals.org/content/early/2019/06/04/2326-6066.CIR-19-0023.full-text.pdf … -
Catch Vigeo CEO, Dr. Jing Watnick’s presentation today at the 2019 BIO Investor Forum happening at 1:00PM ET/10:00 AM PT. Live streaming here: https://bit.ly/2p60riN
#BIF19#immunoncology -
Congrats to all the authors involved in these great 3 papers! Check out the awesome News and Views from
@BCellBruno for a summary#immunoncology#Bcells#TME New predictors for immunotherapy responses sharpen our view of the tumour microenvironmenthttps://www.nature.com/articles/d41586-019-03943-0 … -
GeoVax Reports 2019 Third Quarter Financial Results and Provides Corporate Update https://buff.ly/2CkVQfK
#lassafever#HIV#malaria#immunoncology#vaccines#functionalcure$GOVXpic.twitter.com/cznoz0mjDl
-
#Immunoncology and#vaccine specialist@BioNTech_Group is broadening its antibody discovery capabilities by acquiring MAB Discovery’s antibody generation unit.https://european-biotechnology.com/up-to-date/latest-news/news/biontech-swallows-mab-discovery-antibody-unit.html … -
NanoString is hiring a Sales Support Associate -EMEA https://grnh.se/25e9cabd2 via
@greenhouse#biomarker#genexpression#gene#RNA#mRNA#immunology#immunoncology#oncology#translational#research -
'Strategies to treat immune hot, altered, & cold tumors with combination immunotherapies' overview (J Galon & D Bruni, 2019). https://www.nature.com/articles/s41573-018-0007-y@NatRevDrugDisc …
#immunoncology#immunotherapypic.twitter.com/aegv2PEMAt
-
@NIMMLab develops#immunometabolic models -> assesses how metabolic reprogramming by new therapeutics result in therapeutic outcomes in#autoimmune diseases and#immunoncology https://www.nimml.org/news/detail/immunometabolism-a-promising-gateway-for-accelerated-drug-development …pic.twitter.com/B0m9Dj9vfO
-
@NIMMLab investigates#immunometabolic model -> assesses how metabolic reprogramming of immune response affects the outcomes of#autoimmune diseases and#immunoncology https://nimml.org/news/detail/immunometabolism-a-promising-gateway-for-accelerated-drug-development …pic.twitter.com/ZzYeF6P6BR
-
Investors, don’t miss Dr. Jing Watnick, our CEO, presenting Vigeo’s story at the 2019 BIO Investor Forum next Wednesday, October 23 at 10:00 AM PT. For more details, and a link to the livestream, check out our press release: https://bit.ly/32jK9Bd
#BIF19#immunoncology -
1)Retransplant from a different donor 2)Checkpoint inhibitors 3)IFN-gamma Great work by
@SanRaffaeleMI#leukemia#immunoncology#transplant#alloHCTPrikaži ovu nit -
.
@DrRoyHerbstYale attended the annual JP Morgan Healthcare Conference in San Francisco yesterday to discuss#biotech development and#immunoncology with other@YaleAlumni.@SmilowCancer@YaleMed@YNHHpic.twitter.com/Bof9qypOr5
-
Our leadership will be at
#JPM20 this week, catching the latest in#immunoncology advances and sharing our pipeline's development and advances towards clinical studies. Wishing the team a productive week in San Fran! pic.twitter.com/SsKm1qFW7K
-
NEWSLETTER 2020: Reports an exciting 2019 and reveals a look into what's to come in 2020: (2) planned BLA filings in 2L CC (2) Novel discoveries to IND (6) clinical programs with data, including AGEN1181 + balstilimab https://agenusbio.com/wp-content/uploads/2020/01/NL-200107-2019-year-in-review-v.2.pdf …
#immunoncology#innovationpic.twitter.com/yLlOu3THKj
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.